Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease

Objective. To determine whether IL-18 is involved in the inflammation of DM and PM. Methods. Thirty-three patients with DM were enrolled in this study, including 25 with interstitial lung disease (ILD). In addition, 16 patients with PM were enrolled, including 6 with ILD. All patients were admitted to our hospital as a result of their condition requiring treatment, and clinical laboratory data including serum IL-18 were recorded on admission. Results. Serum IL-18 was significantly (P < 0.0001) higher in both DM and PM patients than in healthy controls (n = 30). Serum ferritin and IL-18 were significantly (P = 0.003 and 0.0044, respectively) higher in DM than in PM patients. Additionally, ferritin and IL-18 were significantly (P = 0.023 and 0.034, respectively) higher in DM patients with ILD than in DM patients without ILD. Significant positive correlations were found between creatine kinase (CK) and ferritin (rs = 0.39, P = 0.024); CK and IL-18 (rs = 0.48, P = 0.005); and IL-18 and ferritin (rs = 0.54, P = 0.0012) in the DM group as a whole. These findings were different for the DM plus ILD subgroup: significant positive correlations were found between CK and ferritin (rs = 0.40, P = 0.047); CK and IL-18 (rs = 0.63, P = 0.0008); and IL-18 and ferritin (rs = 0.41, P = 0.042). Conclusion. Serum IL-18 was strikingly elevated in patients with DM and was associated particularly with disease activity and ILD complication in DM.